Evidence map›Paper›PMID 27226303›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

New paradigm to assess brain cell morphology by diffusion-weighted MR spectroscopy in vivo.

Marco Palombo, Clémence Ligneul, Chloé Najac, Juliette Le Douce, Julien Flament, Carole Escartin, Philippe Hantraye, Emmanuel Brouillet, Gilles Bonvento, Julien Valette

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 105 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Marco PalomboMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France; marco.palombo@cea.fr julien.valette@cea.fr.
Clémence LigneulMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Chloé NajacMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Juliette Le DouceMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Julien FlamentMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Service (UMS) 27, INSERM, F-92260 Fontenay-aux-Roses, France.
Carole EscartinMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Philippe HantrayeMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Service (UMS) 27, INSERM, F-92260 Fontenay-aux-Roses, France.
Emmanuel BrouilletMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Gilles BonventoMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France;
Julien ValetteMIRCen, Institut d'Imagerie Biomédicale, Direction de la Recherche Fondamentale, Commissariat à l'Energie Atomique et aux Energies Alternatives, F-92260 Fontenay-aux-Roses, France; Unité Mixte de Recherche (UMR) 9199 (Neurodegenerative Diseases Laboratory), Université Paris-Sud, Université Paris-Saclay, CNRS, F-92260 Fontenay-aux-Roses, France; marco.palombo@cea.fr julien.valette@cea.fr.
Institut d'Imagerie Biomédicale · FRUniversité Paris-Saclay · FRUniversité Paris-Sud · FRCentre National de la Recherche Scientifique · FRDirection de la Recherche Fondamentale · FR

Funding

European Research Council 336331
6 · The paper itself

Abstract

The brain is one of the most complex organs, and tools are lacking to assess its cellular morphology in vivo. Here we combine original diffusion-weighted magnetic resonance (MR) spectroscopy acquisition and novel modeling strategies to explore the possibility of quantifying brain cell morphology noninvasively. First, the diffusion of cell-specific metabolites is measured at ultra-long diffusion times in the rodent and primate brain in vivo to observe how cell long-range morphology constrains metabolite diffusion. Massive simulations of particles diffusing in synthetic cells parameterized by morphometric statistics are then iterated to fit experimental data. This method yields synthetic cells (tentatively neurons and astrocytes) that exhibit striking qualitative and quantitative similarities with histology (e.g., using Sholl analysis). With our approach, we measure major interspecies difference regarding astrocytes, whereas dendritic organization appears better conserved throughout species. This work suggests that the time dependence of metabolite diffusion coefficient allows distinguishing and quantitatively characterizing brain cell morphologies noninvasively.

Indexed as

BrainAnimalsAstrocytesDiffusion Magnetic Resonance ImagingMacaca fascicularisMaleMiceNeuronscell morphologydiffusion-weighted NMR spectroscopymetabolitesnoninvasive histologynumerical simulations

Identifiers

PMID27226303
PMCPMC4914152
OpenAlexW2394738358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.